Clinical Trial Update: Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating chemotherapy tailored to BRCA1 and RRM1 mRNA status in advanced non-small cell lung cancer. The study aims to person…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Tongji University | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN